- Home
- EQNR vs GSK Comparison
EQNR vs GSK Comparison
Compare EQNR & GSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EQNR
- GSK
- Stock Information
- Founded
- EQNR 1972
- GSK 1715
- Country
- EQNR Norway
- GSK United Kingdom
- Employees
- EQNR N/A
- GSK N/A
- Industry
- EQNR Integrated oil Companies
- GSK Biotechnology: Pharmaceutical Preparations
- Sector
- EQNR Energy
- GSK Health Care
- Exchange
- EQNR Nasdaq
- GSK Nasdaq
- Market Cap
- EQNR 69.9B
- GSK 68.2B
- IPO Year
- EQNR N/A
- GSK N/A
- Fundamental
- Price
- EQNR $24.56
- GSK $33.78
- Analyst Decision
- EQNR Buy
- GSK Hold
- Analyst Count
- EQNR 6
- GSK 5
- Target Price
- EQNR $29.45
- GSK $45.50
- AVG Volume (30 Days)
- EQNR 2.8M
- GSK 3.5M
- Earning Date
- EQNR 02-05-2025
- GSK 02-05-2025
- Dividend Yield
- EQNR 5.49%
- GSK 4.62%
- EPS Growth
- EQNR N/A
- GSK N/A
- EPS
- EQNR 3.27
- GSK 0.81
- Revenue
- EQNR $104,810,000,000.00
- GSK $41,966,224,352.00
- Revenue This Year
- EQNR N/A
- GSK $5.80
- Revenue Next Year
- EQNR N/A
- GSK $3.69
- P/E Ratio
- EQNR $7.03
- GSK $20.19
- Revenue Growth
- EQNR N/A
- GSK 5.59
- 52 Week Low
- EQNR $21.85
- GSK $31.72
- 52 Week High
- EQNR $29.49
- GSK $45.93
- Technical
- Relative Strength Index (RSI)
- EQNR 51.37
- GSK 50.09
- Support Level
- EQNR $25.35
- GSK $31.72
- Resistance Level
- EQNR $25.79
- GSK $34.46
- Average True Range (ATR)
- EQNR 0.42
- GSK 0.47
- MACD
- EQNR 0.03
- GSK 0.06
- Stochastic Oscillator
- EQNR 47.92
- GSK 75.00
About EQNR Equinor ASA
Equinor is a Norway-based integrated oil and gas company. It has been publicly listed since 2001, but the government retains a 67% stake. Operating primarily on the Norwegian Continental Shelf, the firm produced 2.1 million barrels of oil equivalent per day in 2023 (53% liquids) and ended 2023 with 5.2 billion barrels of proven reserves (49% liquids). Operations also include offshore wind, solar, oil refineries and natural gas processing, marketing, and trading.
About GSK GSK plc (Each representing two)
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, antiviral, and vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.